SCHEMBL6638995

SCHEMBL6638995

N#Cc1ccc(CCc2nc3ccc(NS(=O)(=O)c4cccc5cccnc45)cc3o2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PKM P14618 4/20 0.49
GAA P10253 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
PKLR P30613 2/20 0.46
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
ALDH1A1 P00352 4/20 0.45
HTT P42858 2/20 0.44
MAPT P10636 1/20 0.44
F2 P00734 1/20 0.43
GLO1 Q04760 1/20 0.43
TP53 P04637 1/20 0.43
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635303 0.93 PKM (0.51) PKMGAATDP1CYP1A2CYP3A4
SCHEMBL8026426 0.78 MEN1 (0.48) PKMGAATDP1CYP1A2CYP3A4
SCHEMBL8016188 0.78 ALDH1A1 (0.49) PKMGAATDP1CYP1A2CYP3A4
SCHEMBL6635157 0.78 F2 (0.44) PKMALDH1A1MAPTF2
SCHEMBL6633872 0.77 F2 (0.50) PKMGAACYP1A2CYP3A4CYP2D6
SCHEMBL8026354 0.75 F2 (0.74) PKMGAACYP1A2CYP3A4CYP2D6
SCHEMBL8030716 0.75 PKM (0.62) PKMGAATDP1CYP1A2CYP3A4
SCHEMBL6639447 0.75 PKM (0.50) PKMGAATDP1CYP1A2CYP3A4
SCHEMBL6641313 0.75 MEN1 (0.48) PKMGAATDP1CYP1A2CYP3A4
SCHEMBL6633880 0.74 F2 (0.49) PKMGAAPKLRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed